71 related articles for article (PubMed ID: 36588790)
1. Association Between rs217727 and rs2839698 H19 Polymorphisms and Obesity.
Ghafouri-Fard S; Dadyar M; Azizi S; Eslami S; Hussen BM; Taheri M; Rashnoo F
Biochem Genet; 2024 Feb; 62(1):229-241. PubMed ID: 37326896
[TBL] [Abstract][Full Text] [Related]
2. rs217727 of lncRNA H19 is Associated with Cervical Cancer Risk in the Chinese Han Population.
Dai J; Zhang S; Shi Y; Xu J; Liu W; Yang J; Shi L; Yan Z; Li C
Pharmgenomics Pers Med; 2023; 16():933-948. PubMed ID: 37928407
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA (lncRNA)
Liao J; Chen B; Zhu Z; Du C; Gao S; Zhao G; Zhao P; Wang Y; Wang A; Schwartz Z; Song L; Hong J; Wagstaff W; Haydon RC; Luu HH; Fan J; Reid RR; He TC; Shi L; Hu N; Huang W
Genes Dis; 2023 Jul; 10(4):1351-1366. PubMed ID: 37397543
[TBL] [Abstract][Full Text] [Related]
4. Association of lncRNA H19 polymorphisms with cancer susceptibility: An updated meta-analysis based on 53 studies.
Yuan Y; Wang Y; Niu X; Han Y; Li W; Cheng M; Li Z; Tan J; Zhao Y; Wang W
Front Genet; 2022; 13():1051766. PubMed ID: 36588790
[TBL] [Abstract][Full Text] [Related]
5. Association between genetic polymorphisms of long noncoding RNA H19 and cancer risk: a meta-analysis.
Hashemi M; Moazeni-Roodi A; Sarabandi S; Karami S; Ghavami S
J Genet; 2019 Sep; 98():. PubMed ID: 31544800
[TBL] [Abstract][Full Text] [Related]
6. Association between lncRNA H19 polymorphisms and cancer susceptibility based on a meta-analysis from 25 studies.
Liu C; Chen L; You Z; Wu Y; Wang C; Zhang G; Xu B; Chen M
Gene; 2020 Mar; 729():144317. PubMed ID: 31884107
[TBL] [Abstract][Full Text] [Related]
7. Six polymorphisms in the lncRNA H19 gene and the risk of cancer: a systematic review and meta-analysis.
Yang M; Zhang M; Wang Q; Guo X; Geng P; Gu J; Ji W; Zhang L
BMC Cancer; 2023 Jul; 23(1):688. PubMed ID: 37480014
[TBL] [Abstract][Full Text] [Related]
8. Significant association between long non-coding RNA H19 polymorphisms and cancer susceptibility: A PRISMA-compliant meta-analysis and bioinformatics prediction.
Li W; Jiang X; Jin X; Yan W; Liu Y; Li D; Zhao Z
Medicine (Baltimore); 2020 Apr; 99(15):e19322. PubMed ID: 32282694
[TBL] [Abstract][Full Text] [Related]
9. The influence of LncRNA H19 polymorphic variants on susceptibility to cancer: A systematic review and updated meta-analysis of 28 case-control studies.
Wang K; Zhu Z; Wang Y; Zong D; Xue P; Gu J; Lu D; Tu C
PLoS One; 2021; 16(7):e0254943. PubMed ID: 34310645
[TBL] [Abstract][Full Text] [Related]
10. Nanotechnology: A Promising Approach for Cancer Diagnosis, Therapeutics and Theragnosis.
Dessale M; Mengistu G; Mengist HM
Int J Nanomedicine; 2022; 17():3735-3749. PubMed ID: 36051353
[TBL] [Abstract][Full Text] [Related]
11. Association of IKZF1 and CDKN2A gene polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.
Sattarzadeh Bardsiri M; Zehtab S; Karami N; Farsinejad A; Ehsan M; Fatemi A
BMC Med Genomics; 2022 Aug; 15(1):171. PubMed ID: 35932035
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of exercise intervention during pregnancy on high-risk women for gestational diabetes mellitus prevention: A meta-analysis of published RCTs.
Tsironikos GI; Perivoliotis K; Bargiota A; Zintzaras E; Doxani C; Tatsioni A
PLoS One; 2022; 17(8):e0272711. PubMed ID: 35930592
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
